A5020177208- Pain Management and Opioid Use
- Pediatric Pain Management Techniques
- Childhood Cancer Survivors' Quality of Life
- Venomous Animal Envenomation and Studies
- Cancer survivorship and care
- Pain Mechanisms and Treatments
- Pain Management and Placebo Effect
- Palliative Care and End-of-Life Issues
- Peripheral Neuropathies and Disorders
- Opioid Use Disorder Treatment
Prisma Health
2020-2022
University of South Carolina
2022
Virginia Commonwealth University
2017
<sec> <title>BACKGROUND</title> Virtual reality (VR) interventions are increasingly used in healthcare settings to improve patient-reported outcomes (PROs). Measuring PROs commonly evaluated at weekly intervals with data collected via digital surveys. While assessments have benefits, VR devices enable more frequent in-device collection. It remains unclear whether frequently provide information on these than infrequently. </sec> <title>OBJECTIVE</title> We examined daily versus a intervention...
Purpose: Cancer treatment for those nearing death has become increasingly aggressive over time despite evidence that less approaches are associated with better quality of life and sometimes longer survival. Chemotherapy administration in the last 14 days is one proposed benchmarks cancer care. The purpose our study to evaluate factors patients who died within 2 weeks receiving chemotherapy. Methods: This retrospective cohort evaluated adult between 1 February 2018 March 2019 after preceding...
Introduction Patients with advanced cancer often experience high levels of debilitating pain and pain-related psychological distress. Although there is increasing evidence that non-pharmacological interventions are needed to manage their pain, pharmacologic modalities remain the preferred treatment . Guided imagery a form focused relaxation helps create harmony between mind body has been shown significantly improve pain. Our study presents Virtual Reality Assisted Imagery (VRAGI) as...
We report a case of 60-year-old man who was referred to palliative care clinic with monoclonal gammopathy undetermined significance (MGUS)-associated neuropathy, responding therapeutic trial warfarin. Electromyography showed distal symmetric sensory axonal neuropathy. The patient reported having had improvement his neuropathic symptoms while taking warfarin postoperatively for thromboprophylaxis 1 year prior, and recurrence after the discontinued. rechallenged warfarin, targeting an...